ConductScience.org, home

Paper29971069

Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.

Tong Y and 3 others. Front Immunol, 2018. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly. Papers, record 29971069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29971069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
PubMed
Journal
Front Immunol
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.57
iCite
Revised in PubMed
2019-11-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tong YYimin
2Lavillette DDimitri
3Li QQingchao
4Zhong JJin

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121735466Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.Hepatology2011https://conductscience.org/library/papers/21735466PubMed
221555519Identification of interactions in the E1E2 heterodimer of hepatitis C virus important for cell entry.J Biol Chem2011https://conductscience.org/library/papers/21555519PubMed
326958720Mechanisms of Virus Membrane Fusion Proteins.Annu Rev Virol2014https://conductscience.org/library/papers/26958720PubMed
425960762The missing pieces of the HCV entry puzzle.Future Virol2015https://conductscience.org/library/papers/25960762PubMed
524038151Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.Hepatology2014https://conductscience.org/library/papers/24038151PubMed
619891955Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein.Biochim Biophys Acta2010https://conductscience.org/library/papers/19891955PubMed
720962101Hepatitis C virus NS2 protein serves as a scaffold for virus assembly by interacting with both structural and nonstructural proteins.J Virol2011https://conductscience.org/library/papers/20962101PubMed
817537855Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.J Virol2007https://conductscience.org/library/papers/17537855PubMed
929544098Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.Cell Host Microbe2018https://conductscience.org/library/papers/29544098PubMed
1012770768Glycosylation of hepatitis C virus envelope proteins.Biochimie2003https://conductscience.org/library/papers/12770768PubMed
1120668082Characterization of the envelope glycoproteins associated with infectious hepatitis C virus.J Virol2010https://conductscience.org/library/papers/20668082PubMed
1229505618A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.PLoS Pathog2018https://conductscience.org/library/papers/29505618PubMed
1322278231Role of conserved cysteine residues in hepatitis C virus glycoprotein e2 folding and function.J Virol2012https://conductscience.org/library/papers/22278231PubMed
1424018384The ins and outs of hepatitis C virus entry and assembly.Nat Rev Microbiol2013https://conductscience.org/library/papers/24018384PubMed
1525525789The impact of hepatitis C virus entry on viral tropism.Cell Host Microbe2014https://conductscience.org/library/papers/25525789PubMed
1623292515Functional and evolutionary insight from the crystal structure of rubella virus protein E1.Nature2013https://conductscience.org/library/papers/23292515PubMed
1725122793Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins.J Virol2014https://conductscience.org/library/papers/25122793PubMed
1828179528Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.J Virol2017https://conductscience.org/library/papers/28179528PubMed
1914685283Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion.EMBO J2004https://conductscience.org/library/papers/14685283PubMed
2012356718The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.EMBO J2002https://conductscience.org/library/papers/12356718PubMed

See all 66 referencesDownload CSV of references

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42550688The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages.Cell Rep2026https://conductscience.org/library/papers/42550688PubMed
41939904Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance.Front Immunol2026https://conductscience.org/library/papers/41939904PubMed
41673395Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design.Nat Commun2026https://conductscience.org/library/papers/41673395PubMed
40943245Structural and Functional Hallmarks of Sindbis Virus Proteins: From Virion Architecture to Pathogenesis.Int J Mol Sci2025https://conductscience.org/library/papers/40943245PubMed
40193609Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40193609PubMed
40119224A review of historical landmarks and pioneering technologies for the diagnosis of Hepatitis C Virus (HCV).Eur J Clin Microbiol Infect Dis2025https://conductscience.org/library/papers/40119224PubMed
39338314Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39338314PubMed
39232163The hepatitis C virus envelope protein complex is a dimer of heterodimers.Nature2024https://conductscience.org/library/papers/39232163PubMed
38528146Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens.Nat Microbiol2024https://conductscience.org/library/papers/38528146PubMed
38394369Antiviral Protein-Protein Interaction Inhibitors.J Med Chem2024https://conductscience.org/library/papers/38394369PubMed
38107333HCV E1 influences the fitness landscape of E2 and may enhance escape from E2-specific antibodies.Virus Evol2023https://conductscience.org/library/papers/38107333PubMed
36298858Host Cell Receptors Implicated in the Cellular Tropism of BVDV.Viruses2022https://conductscience.org/library/papers/36298858PubMed
34778024Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review.Front Oncol2021https://conductscience.org/library/papers/34778024PubMed
34497798Identification and Characteristics of Fusion Peptides Derived From Enveloped Viruses.Front Chem2021https://conductscience.org/library/papers/34497798PubMed
34404999Antiviral nanoparticles for sanitizing surfaces: A roadmap to self-sterilizing against COVID-19.Nano Today2021https://conductscience.org/library/papers/34404999PubMed
34070716Viral Manipulation of the Host Epigenome as a Driver of Virus-Induced Oncogenesis.Microorganisms2021https://conductscience.org/library/papers/34070716PubMed
34069740HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development.Cancers (Basel)2021https://conductscience.org/library/papers/34069740PubMed
34064532From Structural Studies to HCV Vaccine Design.Viruses2021https://conductscience.org/library/papers/34064532PubMed
33455472Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors.J Enzyme Inhib Med Chem2021https://conductscience.org/library/papers/33455472PubMed
33092458Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.Channels (Austin)2020https://conductscience.org/library/papers/33092458PubMed

See all 30 cited byDownload CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29971069

GET https://conductscience.org/api/papers/v1/29971069/references?page=2